Cases & Deals

Ambit Biosciences develops patent portfolio for small molecule kinase inhibitor programs

Clients Ambit Biosciences

Jones Day represented Ambit Biosciences in the development of patent portfolios related to small molecule kinase inhibitor programs and phage-displayed protein assays.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.